Skip to content

Clinical trials

Cholangiocarcinoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Switzerland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20122
20142
20172
20191
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich4
Amgen1
Basilea Pharmaceutica1
Bayer1
Concordia Laboratories Inc.1
Incyte Corporation1
Maastricht University1
Maastricht University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Carcinoma, Hepatocellular3
Liver Neoplasms3
Bile Duct Neoplasms2
Klatskin Tumor2
Pancreatic Neoplasms2
Triple Negative Breast Neoplasms2
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.